AVAH (Aveanna Healthcare Holdings Inc. Common Stock) Stock Analysis - News
Aveanna Healthcare Holdings Inc. Common Stock (AVAH) is a publicly traded Healthcare sector company. As of May 21, 2026, AVAH trades at $7.50 with a market cap of $1.68B and a P/E ratio of 6.83. AVAH moved +0.66% today. Year to date, AVAH is -6.57%; over the trailing twelve months it is +33.57%. Its 52-week range spans $3.67 to $10.32. Analyst consensus is buy with an average price target of $9.94. Rallies surfaces AVAH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in AVAH news today?
Aveanna Raises 2026 Revenue Guidance to $2.56–2.58B, Targets $328M–332M EBITDA: Aveanna Healthcare raised full-year 2026 revenue guidance to $2.56–2.58 billion and adjusted EBITDA to $328–332 million, driven by a one-time $6 million receivables collection in Q1. The company said the Medicare home health licensure moratorium won’t affect operations and expects the Family First deal to close in late Q2.
Aveanna Raises 2026 Revenue Guidance to $2.56–2.58B, Targets $328M–332M EBITDA: Aveanna Healthcare raised full-year 2026 revenue guidance to $2.56–2.58 billion and adjusted EBITDA to $328–332 million, driven by a one-time $6 million receivables collection in Q1. The company said the Medicare home health licensure moratorium won’t affect operations and expects the Family First deal to close in late Q2.
Does Rallies summarize AVAH news?
Yes. Rallies summarizes AVAH news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is AVAH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AVAH. It does not provide personalized investment advice.
